Skip to main content

Opioid News

Narcan (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration

January 25, 2017 – Dublin, Ireland – Today, the U.S. Food and Drug Administration (FDA) approved Narcan Nasal Spray as a 2mg formulation for the emergency treatment of known or suspected opioid ove...

Collegium Receives FDA Approval for Xtampza ER, an Analgesic with Abuse-Deterrent Properties

CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) – Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza ER (oxycodone)...

Ask a question

To post your own question to this support group, sign in or create an account.